CPAP Adherence

Colin M. Shapiro, BSc (Hons), MBBCH, PhD, MRC Psych., FRCP(C): Professor Emeritus, Department of Psychiatry and Ophthalmology, University of Toronto Toronto, Ontario, Canada Dr. Shapiro was the founding president of the British Sleep Society and the International Neuropsychiatry Association. He has run sleep facilities on three continents. His interest in CPAP adherence stems from his background in psychiatry and his interest in helping people to make behavioural change. Meenakshi Gupta MD, MBChB, MMed Dr Gupta is an Internist from Zambia. She is currently working in Saskatchewan, Canada and has an interest in health promotion. Dora Zalai, MD, PhD, C. Psych.: Dr Zalai has a dual background in medicine and psychology. She integrates biological and psychological perspectives in her clinical work to develop and establish person-centred, individually tailored, effective and enduring treatments for individuals with sleep disorders. Dr. Zalai leads the behavioural sleep medicine program at Sleep on the Bay (Toronto, Canada) that provides evidence-based evaluation and treatment for the full spectrum of sleep and circadian disorders in an inter-disciplinary setting.

PART 1.- 1. When To Treat With Cpap And How To Define Success.- 2. Interventions to Improve CPAP Adherence.- 3. Patient Adherence to CPAP- A Practical Interdisciplinary Model.- 4. Soft Styles of Motivating Patients to Adopt CPAP.- 5. The role of education and support in CPAP adherence.- 6. Role of the Behavioural Sleep Specialist Psychologist in Promoting CPAP Adherence.- 7. Role of the physician in CPAP adherence and CPAP trials.- 8. PAP Therapy for Sleep Breathing Disorders: Good Policies and Practices.- PART 2.- 9. Socio-Economic Differences in CPAP Adherence.- 10. The Impact of Partner and Family Support.- 11. Personality and Mental Health as Determinants of CPAP Use.- 12. Costs of Treatment Non-adherence in Obstructive Sleep Apnoea.- 13. Obstructive Sleep Apnea Phenotypes And Positive Airway Therapy Adherence.- PART 3.- 14. PAP Adherence in Neurology Patients.- 15. Obstructive Sleep Apnea, CPAP and Impact on Cognitive Function.- 16. Sleep Apnea and Cardiovascular Disease: TheRole of CPAP and CPAP.- 17. Cognitive Behavioural Therapy for Insomnia in Patients with Comorbid Insomnia and Obstructive Sleep Apnea.- 18. Overview of Medication Treatment for Comorbid Insomnia and Obstructive Sleep Apnea (COMISA).- 19. CPAP Adherence in Patients with Obstructive Sleep Apnea and Depression.- 20. Adherence with Treatment for Sleep Apnea in Patients with Co-morbid Post-Traumatic Stress Disorder.- 21. ReleVancouvere of CPAP in Ophthalmic Disease.- 22. CPAP Adherence and Bariatric Surgery Patients.- 23. CPAP adherence in pregnancy.- PART 4.- 24. Pathophysiology of Obstructive Sleep Apnea in Children ReleVancouvere to Treatment Approaches.- 25. PAP Management and Adherence for Children and Adolescents with OSAS.- 26. Cpap Adherence In Children With Special Health Care Needs.- . PART 5.- 27. Monitoring of the Patient on CPAP and When should Alternative Treatment Modalities be Considered.- 28. Oral Appliance Use for Sleep Related Breathing Disorders.- 29. Utilization of wake promoting drugs in patients on CPAP therapy.- 30. Improving CPAP Adherence using Telehealth.- 31. The CPAP Machine, Mask and Interface.- 32. How to Start Using and Benefit from CPAP Use_ A CPAP Vendor's Practical Information to Patients.- 33. The CPAP treatment Coordinator's Role in Helping Patients with CPAP Use.- 34. The Respiratory Therapist and the Vendor's Perspective on CPAP Adherence.- 35. Global Perspective on CPAP Adherence.- 36. Questionnaires Evaluating Sleep Apnea and CPAP Adherence.- 37. The Past and Future of CPAP.